Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07568756
PHASE2
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation
Sponsor: University of California, Irvine
View on ClinicalTrials.gov
Summary
This is a phase II single arm, open-label clinical trial determining diagnostic accuracy of Flotufolastat F18 PET in subjects with prostate adenocarcinoma. These are subjects who have not previously received treatment for prostate cancer.
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-05
Completion Date
2029-05
Last Updated
2026-05-06
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
Flotufolastat F18 PET
Flotufolastat F18 PET
Locations (1)
Chao Family Comprehensive Cancer Center, University of California, Irvine
Orange, California, United States